ERYTECH Pharma announces the oral presentation of positive Phase II clinical trial results in Acute Lymphoblastic Leukemia. Post author:admERY Post published:June 17, 2012 Post category:Newsroom You Might Also Like ERYTECH Provides Business Update and Reports Financial Results for First Quarter 2019 May 6, 2019 ERYTECH to Present Pharmacodynamic Data from Phase 2/3 Trial of Eryaspase in ALL at ASCO 2018 June 4, 2018 ERYTECH reports additional positive Phase III results from clinical study with eryaspase/GRASPA® in Acute Lymphoblastic Leukemia December 8, 2014
ERYTECH to Present Pharmacodynamic Data from Phase 2/3 Trial of Eryaspase in ALL at ASCO 2018 June 4, 2018
ERYTECH reports additional positive Phase III results from clinical study with eryaspase/GRASPA® in Acute Lymphoblastic Leukemia December 8, 2014
